Pulmonary Embolism Pe clinical trials

Explore recruiting pulmonary embolism pe clinical trials.

Recruiting pulmonary embolism pe studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pulmonary Embolism Pe trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Avoiding Risks of Thrombosis and bleeding in Surgery (ARTS): an international randomised controlled trial evaluating apixaban versus no anticoagulation in patients undergoing general abdominal, gynecologic and urologic surgery

Finland

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 3, Multicenter, Randomized, Open-Label, Study to Evaluate REGN7508, A Factor XI Monoclonal Antibody, Versus Apixaban and Enoxaparin for Prophylaxis of Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-APEX).

Bulgaria, Lithuania, Poland, Hungary, Latvia, Romania

Therapeutic confirmatory (Phase III) EU CTIS Study details

Clinical Surveillance vs. Anticoagulation for Low-risk Patients with Isolated Subsegmental Pulmonary Embolism: A Multicenter Randomized Placebo-Controlled Non-Inferiority Trial

Netherlands, France, Belgium

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 3, Multicenter, Double-Blinded, Randomized Study to Evaluate REGN7508, a Factor XI Monoclonal Antibody, Versus Acetylsalicylic Acid for Prophylaxis of Symptomatic Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-ASPEN)

Greece, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

API-AHAI - Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation after CABG - PACeS

Germany

Therapeutic use (Phase IV) EU CTIS Study details

Pulmonary Embolism Pe trials by city

Pulmonary Embolism Pe in Toronto Pulmonary Embolism Pe in Vancouver Pulmonary Embolism Pe in Montreal Pulmonary Embolism Pe in Calgary Pulmonary Embolism Pe in Edmonton Pulmonary Embolism Pe in Ottawa Pulmonary Embolism Pe in Winnipeg Pulmonary Embolism Pe in Quebec City Pulmonary Embolism Pe in Hamilton Pulmonary Embolism Pe in Kitchener Pulmonary Embolism Pe in London Pulmonary Embolism Pe in Halifax Pulmonary Embolism Pe in New York Pulmonary Embolism Pe in Los Angeles Pulmonary Embolism Pe in Chicago Pulmonary Embolism Pe in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease